Home › Premarket Biotech Digest: Gilead And HCV Drug Pricing, Relypsa Rumors, Amgen-Merck Collaboration
 

Keywords :   


Premarket Biotech Digest: Gilead And HCV Drug Pricing, Relypsa Rumors, Amgen-Merck Collaboration

2015-12-07 17:45:48| Biotech - Topix.net

Our regular management interview will be held on our subscription panel today at 11am EST with Dr Todd Brady, MD, PhD, CEO of Aldeyra . Please buy a discounted subscription to participate in the panel discussion, and other discussions held regularly for subscribers.

Tags: drug pricing collaboration digest

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
05.11Boeing strike ends as workers back 38% pay rise deal
05.11Tropical Storm Rafael Public Advisory Number 6A
05.11Summary for Tropical Storm Rafael (AT3/AL182024)
05.11Tropical Storm Rafael Graphics
05.11Atlantic Tropical Weather Outlook
05.11Eastern North Pacific Tropical Weather Outlook
05.11Tropical Storm Rafael Graphics
05.11Tropical Storm Rafael Forecast Discussion Number 6
More »